Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2020 09:05 ET | Source: Stereotaxis, Inc.

Benefits of Stereotaxis Robotic Technology in COVID-19 Patient Highlighted in Publication

ST. LOUIS, July 13, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in...
June 22, 2020 09:05 ET | Source: Stereotaxis, Inc.

Stereotaxis to be Added to the Russell 2000® and Russell 3000® Indexes

ST. LOUIS, June 22, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that the company...
June 18, 2020 09:05 ET | Source: Stereotaxis, Inc.

Stereotaxis to Present at Cowen 5th Annual FutureHealth Conference

ST. LOUIS, June 18, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
June 10, 2020 09:00 ET | Source: Stereotaxis, Inc.

Pioneering Efforts in TeleRobotic Surgery Focus of Webcast Symposium on June 20th

New Leadership Council Announced to Advance Adoption of TeleRoboticsFirst Bi-Directional TeleRobotic Surgery Broadcast LiveST. LOUIS, June 10, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the...
June 02, 2020 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Robotic Technology Now Referenced In Over 400 Scientific Publications

Over 400 scientific publications now document clinical benefits of Stereotaxis robotic technologyMost recent publication reviews outcomes of 1,003 consecutive robotic procedures at a single center ...
May 26, 2020 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Announces $15 Million Common Stock Financing

ST. LOUIS, May 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it has...
May 05, 2020 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2020 First Quarter Financial Results

ST. LOUIS, May 05, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
April 30, 2020 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Report First Quarter 2020 Financial Results on May 5, 2020

ST. LOUIS, April 30, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
March 10, 2020 08:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2019 Full Year Financial Results

ST. LOUIS, March 10, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial...
March 06, 2020 08:05 ET | Source: Stereotaxis, Inc.

Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System

ST. LOUIS, March 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received...